GH

GeneDx Holdings Corp.

WGS·NASDAQ

$53.02

+2.0%
HealthcareMedical - Healthcare Information Services

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

At a Glance

Live Snapshot
Market Cap$1.57B
EPS-0.7300
P/E Ratio-72.63
Earnings Date08/04/2026

wgs

Research Development Expenses

Last Annual Value

72.03M

3-Year CAGR

-6%

5-Year CAGR

%

10-Year CAGR

8%

GH

GeneDx Holdings Corp. Competitors Analysis of research-development-expenses

WGS · NASDAQ
Companyresearch-development-expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
72.03M
7.3%-7.3%N/A 
0.00
N/AN/AN/A
141.83M
-3.8%37.4%N/A
316.60M
18.7%18.2%N/A
368.14M
49.6%N/AN/A
344.95M
75.5%50.3%44.0%
0.00
N/AN/AN/A
IMVT logo
Immunovant, Inc.
NASDAQ:IMVT
456.66M
41.8%46.1%N/A
69.06M
3.0%25.4%16.0%
332.06M
25.4%31.6%51.8%
0.00
N/AN/AN/A
GH

GeneDx Holdings Corp. Fair Value Envelope

WGS · NASDAQ

Our analysis suggests that WGS has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $53.02, this represents a potential HIDDEN relative to our calculated worth for GeneDx Holdings Corp..

Intrinsic Value
Current Price: $53.02